Tus kws kho mob
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1491 - 1500 ntawm 3685
Tus kws kho mob
QP30-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP31-23 Commercial Pharmacy Benefit Exclusion for Fluticasone-Salmeterol
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
P18-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2023
Tus kws kho mob
P19-23 Updated Reimbursement Policy: Preventive Medicine Services, Effective June 5, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2023
Tus kws kho mob
P21-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2023
Tus kws kho mob
Long Acting Insulin - Commercial
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Afrezza® - Medicaid
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Hyftor™ (sirolimus) - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P22-23 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective June 5, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2023